Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo

Biochemical and Biophysical Research Communications

Volumn 409, Issue 3, 2011, Pages 483-488

  Yamamichi, Shingo ^a   Fujiwara, Yukari ^a   Kikuchi, Tadashi ^a   Nishitani, Miki ^a   Matsushita, Yasuhiko ^a   Hasumi, Keiji ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

2 Antiplasmin; Autoactivation; FSAP; Histone; PHBP; Sepsis

Indexed keywords

ALPHA 2 ANTIPLASMIN; BINDING PROTEIN; BRADYKININ; HISTONE; LIPOPOLYSACCHARIDE; PLASMA HYALURONAN BINDING PROTEIN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CIRCULATION; COMPLEX FORMATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INJECTION; MEDIATOR; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN SECRETION; SEPSIS;

ANIMALS; ENZYME ACTIVATION; FEMALE; HISTONES; HUMANS; INFLAMMATION; MICE; MICE, INBRED ICR; SERINE ENDOPEPTIDASES;

MUS;

EID: 79958218315     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.030     Document Type: Article

References (31)

1. Choi-Miura N.H., Tobe T., Sumiya J., Nakano Y., Sano Y., Mazda T., Tomita M. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain similar to hepatocyte growth factor activator. J. Biochem. (Tokyo) 1996, 119:1157-1165.
2. Römisch J., Vermohlen S., Feussner A., Stöhr H.A. The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 1999, 29:292-299.
3. Hunfeld A., Etscheid M., Konig H., Seitz R., Dodt J. Detection of a novel plasma serine protease during purification of vitamin K-dependent coagulation factors. FEBS Lett. 1999, 456:290-294.
4. Römisch J., Feussner A., Vermohlen S., Stöhr H.A. A protease isolated from human plasma activating factor VII independent of tissue factor. Blood Coagul. Fibrinolysis 1999, 10:471-479.
5. Etscheid M., Beer N., Fink E., Seitz R., Dodt J. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin. Biol. Chem. 2002, 383:1633-1643.
6. Etscheid M., Beer N., Kreß J., Seitz R., Dodt J. Inhibition of bFGF/EGF-dependent endothelial cell proliferation by t0he hyaluronan-binding protease from human plasma. Eur. J. Cell. Biol. 2004, 82:597-604.
7. Kannemeier C., Al Fakhr N., Preissner K.T., Kanse S.M. Factor VII activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells. FASEB J. 2004, 18:728-730.
8. Willeit J., Kiechl S., Weimer T., Mair A., Santer P., Wiedermann C.J., Roemisch J., Marburg I. Polymorphism of factor VII-activating protease a prominent risk predictor of carotid stenosis. Circulation 2003, 107:667-670.
9. Ireland H., Miller G.J., Webb K.E., Cooper J.A., Humphries S.E. The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. J. Thromb. Haemost. 2002, 92:986-992.
10. Choi-Miura N.H., Otsuyama K., Sano Y., Saito K., Takahashi K., Tomita M. Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form. Biol. Pharm. Bull. 2001, 24:892-896.
11. Wygrecka M., Morty R.E., Markart P., Kanse S.M., Andreasen P.A., Wind T., Guenther A., Preissner K.T. Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome. J. Biol. Chem. 2007, 282:21671-21682.
12. Etscheid M., Hunfeld A., Konig H., Seitz R., Dodt J. Activation of proPHBSP the zymogen of a plasma hyaluronan binding serine protease by an intermolecular autocatalytic mechanism. J. Biol. Chem. 2000, 381:1223-1231.
13. Choi-Miura N.H., Saito K., Takahashi K., Yoda M., Tomita M. Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. Biol. Pharm. Bull. 2001, 24:221-225.
14. Nakazawa F., Kannemeier C., Shibamiya A., Song Y., Tzima E., Schubert U., Koyama T., Niepmann M., Trusheim H., Engelmann B., Preissner K.T. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Biochem. J. 2005, 385:831-838.
15. Kannemeier C., Feussner A., Stöhr H.A., Weisse J., Preissner K.T., Römisch J. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Eur. J. Biochem. 2001, 268:3789-3796.
16. Yamamichi S., Nishitani M., Nishimura N., Matsushita Y., Hasumi K. Polyamine-promoted autoactivation of plasma hyaluronan-binding protein. J. Thromb. Haemost. 2010, 8:559-566.
17. Zeerleder S., Zwart B., Velthuis H., Stephan F., Manoe R., Rensink I., Aarden L.A. Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP). FASEB J. 2008, 22:4077-4084.
18. Zeerleder S., Zwart B., Wuillemin W.A., Aarden L.A., Groeneveld A.B., Caliezi C., van Nieuwenhuijze A.E., van Mierlo G.J., Eerenberg A.J., Lämmle B., Hack C.E. Elevated nucleosome levels in systemic inflammation and sepsis. Crit. Care. Med. 2003, 31:1947-1951.
19. Holdenrieder S., Nagel D., Schalhorn A., Heinemann V., Wilkowski R., Von Pawel J., Raith H., Feldmann K., Kremer A.E., Müller S., Geiger S., Hamann G.F., Seidel D., Stieber P. Clinical relevance of circulating nucleosomes in cancer. Ann. N Y Acad. Sci. 2008, 1137:180-189.
20. Xu J., Zhang X., Pelayo R., Monestier M., Ammollo C.T., Semeraro F., Taylor F.B., Esmon NL., Lupu F., Esmon C.T. Extracellular histones are major mediators of death in sepsis. Nat. Med. 2009, 15:1318-1321.
21. Mattsson E., Herwald H., Cramer H., Persson K., Sjöbring U., Björck L. Staphylococcus aureus induces release of bradykinin in human plasma. Infect. Immun. 2001, 69:3877-3882.
22. Alessi M.C., Bastelica D., Mavri A., Morange P., Berthet B., Grino M., Juhan-Vague I. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1262-1268.
23. Kirschfink M., Nurnberger W. C1 inhibitor in anti-inflammatory therapy from animal experiment to clinical application. Mol. Immunol. 1999, 36:225-232.
24. Lijnen H.R., Okada K., Matsuo O., Collen D., Dewerchin M. α2-Antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Blood 1999, 93:2274-2281.
25. Clark S.R., Ma A.C., Tavener S.A., McDonald B., Goodarzi Z., Kelly M.M., Patel K.D., Chakrabarti S., McAvoy E., Sinclair G.D., Keys E.M., Allen-Vercoe E., Devinney R., Doig C.J., Green F.H., Kubes P. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 2007, 13:463-469.
26. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
27. Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D., K Wrobleski S., Wakefield T.W., Hartwig J.H., Wagner D.D. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. USA 2010, 107:15880-15885.
28. Hasumi K., Yamamichi S., Harada T. Small molecule modulators of the zymogen activation in the fibrinolytic and coagulation systems. FEBS J. 2010, 277:3675-3687.
29. Nishimura N., Takai M., Yamamoto E., Hasumi K. Purpurin as a specific inhibitor of spermidine-induced autoactivation of the protease plasma hyaluronan-binding protein. Biol. Pharm. Bull. 2010, 33:1430-1433.
30. Sekido C., Nishimura N., Takai M., Hasumi K. Inhibition of plasma hyaluronan-binding protein autoactivation by laccaic acid. Biosci. Biotechnol. Biochem. 2010, 74:2320-2322.
31. Yamamoto E., Nishimura N., Okada K., Sekido C., Yamamichi S., Hasumi K. Inhibitors of autoactivation of plasma hyaluronan-binding protein (factor VII activating protease). Biol. Pharm. Bull. 2011, 34:462-470.